In vitro response of cervical cancer cell lines CaSki, HeLa, and ME-180 to the antiestrogen tamoxifen
dc.contributor.author | Grenman, Seija E. | en_US |
dc.contributor.author | Shapira, Amnon | en_US |
dc.contributor.author | Carey, Thomas E. | en_US |
dc.date.accessioned | 2006-04-07T20:17:59Z | |
dc.date.available | 2006-04-07T20:17:59Z | |
dc.date.issued | 1988-06 | en_US |
dc.identifier.citation | Grenman, Seija, Shapira, Amnon, Carey, Thomas E. (1988/06)."In vitro response of cervical cancer cell lines CaSki, HeLa, and ME-180 to the antiestrogen tamoxifen." Gynecologic Oncology 30(2): 228-238. <http://hdl.handle.net/2027.42/27273> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WG6-4C5H0T4-1CK/2/7695951b5ca44048c04defd17a93f952 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/27273 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3371749&dopt=citation | en_US |
dc.description.abstract | The effect of tamoxifen, a nonsteroidal antiestrogenic drug, on the in vitro growth of three cell lines derived from carcinoma of the uterine cervix (HeLa, CaSki, ME-180) was studied using the breast cancer cell line MCF-7 as a tamoxifen-sensitive control. Logarithmically growing cells were fed daily with medium containing 5% dextran-charcoaltreated fetal bovine serum (D5) and 0, 1, 2.5, 5, 7.5, or 10 [mu]M tamoxifen. The cell number in replicate cultures was assessed every other day by cell counts. Growth inhibition was expressed as the percentage of the cell number in control cultures fed with D5. At a concentration of 5 [mu]M tamoxifen, a clear decrease in cell proliferation, resulting in 66-74% inhibition of growth, was observed with MCF-7, HeLa, and ME-180 after 6 days of exposure to tamoxifen. Doses greater than 5 [mu]M resulted in cytotoxicity and progressive cell loss. With the CaSki cell line, 2.5 [mu]M tamoxifen induced more than 60% growth inhibition and 5 [mu]M tamoxifen was cytotoxic. Tamoxifen-induced growth inhibition was reversed by removing tamoxifen from the cell cultures, and the cells resumed logarithmic growth after a lag period of 24-48 hr. MCF-7, but not the cervical carcinoma, lines required estradiol for complete and rapid recovery of logarithmic growth. Our results indicate that tamoxifen inhibits cell growth of these cervical carcinoma cell lines by a mechanism different from that in MCF-7. | en_US |
dc.format.extent | 783516 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | In vitro response of cervical cancer cell lines CaSki, HeLa, and ME-180 to the antiestrogen tamoxifen | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Ophthalmology | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Cancer Research Laboratory of the Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan 48109, U.S.A.; visiting fellow from the Department of Obstetrics and Gynecology, The University of Turku, Turku, Finland | en_US |
dc.contributor.affiliationum | Cancer Research Laboratory of the Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan 48109, U.S.A.; Department of Otolarynology, Kaplan Hospital, Rehovot, Israel | en_US |
dc.contributor.affiliationum | Cancer Research Laboratory of the Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan 48109, U.S.A. | en_US |
dc.identifier.pmid | 3371749 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/27273/1/0000289.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0090-8258(88)90029-7 | en_US |
dc.identifier.source | Gynecologic Oncology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.